Lymphoma Definition

Cancer is a complex, confusing, and ever-shifting field of medicine. While we know and understand more about the disease today than we did forty, twenty, even five years ago, there is still plenty that is not understood. As new insights come to light and disprove previously held theories, the definition of cancer changes.

Defining Lymphoma

Regarding the definition of lymphoma specifically, at its most fundamental it is a disease that originates in blood cells known as lymphocytes. Healthy lymphocytes traverse the body by way of the lymphatic system looking for foreign invaders such as bacteria, and their job is simple: kill them. In this way, lymphocytes work to keep us healthy and free of illness-causing pathogens.

The Lymphatic System

The lymphatic system is part of our immune system. It includes lymphocytes, a fluid called lymph, a network of fluid vessels, weigh-stations along the network known as nodes, and a handful of organs: notably the spleen, the thymus, the tonsils, and the bone marrow.

Cell Division and Apoptosis

Lymphocytes have a life cycle. They are born and they die. They also undergo cell division, a process wherein one cell divides into two daughter cells that are supposed to be identical to the original cell. Healthy cells are programmed to carry out certain functions, then begin a process called apoptosis, which results in the natural death of the cell.

However, the process of cell division is extraordinarily complicated, and sometimes, mistakes occur. Sometimes, these mistakes lead to the shutting down of certain cellular functions; in the case of cancer, the process of apoptosis is normally turned off, allowing for the cancerous cells to proliferate out of control in the body.

This proliferation is a very simple explanation of what happens in cancer. In lymphoma, cancerous lymphocytes proliferate instead of dying. For this reason, lymphoma is considered a lymphoproliferative disorder.

Compared to healthy lymphocytes, malignant lymphocytes are often large or misshapen. They have a tendency to accumulate at the lymph nodes, which causes the nodes to swell. The condition of swollen lymph nodes is called adenopathy.

However, cancerous lymphocytes do not always collect at the lymph nodes. The lymphatic system is great for fighting infections because it traverses the entire body, but it also means that if a cancer should develop in lymphocytes, it can start virtually anywhere in the body. Therefore, lymphomas are divided into nodal lymphomas—those originating and affecting a cluster of lymph nodes—and extranodal lymphomas—those originating and affecting regions of the body beyond the lymph nodes.

Lymphoma Definition: Subtypes

Lymphoma becomes extremely confusing when talk turns to subtypes of lymphoma, such as Hodgkin's lymphoma, non-Hodgkin's lymphoma, follicular lymphoma, diffuse large B-cell lymphoma, anaplastic large T-cell lymphoma, and many more. However, suffice to say that when lymphocytes become cancerous, they can become cancerous in dozens of different ways. When diagnosing lymphoma, a pathologist looks for certain identifiers and performs other lab techniques in order to determine which type of lymphoma.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap